Tyrosine kinase inhibitors

Details for Australian Patent Application No. 2003241326 (hide)

Owner Merck & Co., Inc.

Inventors Wu, Zhicai; Bilodeau, Mark T.; Fraley, Mark E.

Agent Spruson & Ferguson

Pub. Number AU-B-2003241326

PCT Number PCT/US03/13353

PCT Pub. Number WO2003/092595

Priority 60/377,502 02.05.02 US

Filing date 28 April 2003

Wipo publication date 17 November 2003

Acceptance publication date 1 May 2008

International Classifications

A61K 31/437 (2006.01)

A61K 31/09 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/444 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 31/737 (2006.01) - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/377,502 02.05.02 US

8 January 2004 Application Open to Public Inspection

  Published as AU-B-2003241326

1 May 2008 Application Accepted

  Published as AU-B-2003241326

28 August 2008 Standard Patent Sealed

26 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003241327-AMIDINYLPHENYL COMPOUNDS AND THEIR USE AS FUNGICIDES

2003241325-Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression